Victor G Prieto

34PUBLICATIONS
109CO-AUTHORS
Cancer diagnosisMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Jul 30, 2026
Enhanced Melan-A Red Chromogen Labeling in Melanoma Compared to Nevus Cells: A Diagnostic Aid in Dual Multiplex Immunohistochemistry With Ki67.

|Jun 05, 2026
Dermatologic Toxicities Associated With Novel Pan-RAS/RAF Inhibitors.

|Jan 18, 2026
Bispecific Dual-Immune Checkpoint Inhibitor Associated Cutaneous Toxicity: A Report of Lorigerlimab Adverse Skin Reaction in Two Cancer Patients.

Niloofar Sina, Fiorinda Muhaj, Volha Lenskaya

|Jul 10, 2025
Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma.

Elizabeth M Burton, Denái R Milton, Michael T Tetzlaff

|May 07, 2025
Upregulation of MMP9 expression in postradiation angiosarcoma of the breast: a possible predictive risk factor.

Qingqing Ding, Phyu P Aung, Hongxia Sun

|Jan 06, 2025
Genomic and Transcriptomic Profiling of Digital Papillary Adenocarcinomas Reveals Alterations in Matrix Remodeling and Metabolic Genes.

Erol Can Bayraktar, Phyu P Aung, Pavandeep Gill

Pageof 6

Frequent Collaborators

19 joint publications

Carlos Torres-Cabala

16 joint publications

Phyu P Aung

15 joint publications

Jonathan L Curry

15 joint publications

Priyadharsini Nagarajan